市場調査レポート

商品コード

1593510

新生児スクリーニングの市場規模・シェア・成長分析 (製品別、技術別、検査の種類別、地域別)：産業予測 (2024～2031年)

Newborn Screening Market Size, Share, Growth Analysis, By Product (Consumables, Instruments), By Technology (Tandem Mass Spectrometry, Pulse Oximetry), By Test Type (Dry Blood Spot Test, CCHD), By Region - Industry Forecast 2024-2031

出版日: 2024年11月15日
発行: SkyQuest
ページ情報: 英文 177 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 779,047円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 911,338円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,043,629円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
目次

概要

サンプル依頼リストに入れる

新生児スクリーニングの世界市場規模は2023年に12億5,000万米ドルと評価され、2024年の13億4,000万米ドルから2031年には21億2,000万米ドルに成長し、予測期間 (2024～2031年) のCAGRは6.8%で成長する見通しです。

出生率の上昇、乳幼児の先天性疾患の増加、消費者意識の高まり、政府の支援策などが相まって、新生児スクリーニング分野は力強い成長軌道を描いています。世界保健機関 (WHO) は、先天性疾患が生後28日以内の新生児死亡の原因として年間約24万人、生後1ヵ月から5歳までの小児死亡が約17万人に上ることを指摘し、事態の深刻さを強調しています。具体的には、インドにおける先天性代謝異常の有病率は2%から7.8%で、先天性甲状腺機能低下症は新生児1,000人のうち2.1人が罹患しており、検査が普及するにつれて大きな市場の可能性があることを示しています。スクリーニング手法の技術進歩により、より効率的で効果的な手法が利用可能になるにつれて、市場の成長をさらに促進しています。さらに、マニトバ州が2022年6月に開始した、脊髄性筋萎縮症を含めるために新生児スクリーニングを拡大するイニシアチブのような政府主導のプログラムは、スクリーニングの状況を強化し、スクリーニング・プロトコルの幅広い採用と実施を促す役割を果たします。先天性疾患に対する理解が深まり、早期発見が社会的に重視されるようになるにつれ、新生児スクリーニング市場は2031年までかなりの拡大が見込まれます。これらの要素が集約されることで、新生児スクリーニングに対する技術革新と投資に有利な環境が確立され、医療分野の利害関係者にとって重要な注目分野と位置づけられます。

北米 (製品別、検査別、技術別、エンドユーザー別)
- 米国
- カナダ
欧州 (製品別、検査別、技術別、エンドユーザー別)
- 英国
- ドイツ
- スペイン
- フランス
- イタリア
- その他欧州
アジア太平洋 (製品別、検査別、技術別、エンドユーザー別)
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ (製品別、検査別、技術別、エンドユーザー別)
- ブラジル
- その他ラテンアメリカ
中東・アフリカ (製品別、検査別、技術別、エンドユーザー別)
- 湾岸協力会議 (GCC) 諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング (2023年)
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析 (2023年)
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の対前年成長率 (YoY) の比較 (2021～2023年)

主要企業プロファイル

Masimo Corp.
Covidien Plc
AB Sciex LLC
Natus Medical Inc.
Agilent Technologies Inc.
PerkinElmer Inc.
GE Healthcare
Bio-Rad Laboratories Inc.
Trivitron Healthcare
Medtronic Inc.
Rady Children's Institute for Genomic Medicine
GE Lifesciences
Waters Corporation
Danaher Corporation
Thermo Fisher Scientific Inc.
ZIVAK TECHNOLOGIES
CAMAG
OTODYNAMICS
ZENTECH
VIVOSONIC

結論と推奨事項

Product Code: SQMIG35E2050

Global Newborn Screening Market size was valued at USD 1.25 Billion in 2023 and is poised to grow from USD 1.34 Billion in 2024 to USD 2.12 Billion by 2031, growing at a CAGR of 6.8% in the forecast period (2024-2031).

Market insights reveal a robust growth trajectory for the newborn screening sector, driven by a combination of rising birth rates, increasing congenital illnesses among infants, heightened consumer awareness, and supportive government initiatives. The World Health Organization highlights the gravity of the situation, noting that congenital disorders are responsible for approximately 240,000 neonatal deaths annually within the first 28 days of birth, and around 170,000 child deaths from one month to five years old. Specifically, the prevalence of in-born metabolic disorders in India ranges from 2% to 7.8%, with congenital hypothyroidism affecting 2.1 out of every 1,000 newborns, indicating a significant market potential as testing becomes more prevalent. Technological advancements in screening methodologies are further propelling market growth, as more efficient and effective techniques become available. Additionally, government-led programs, such as Manitoba's initiative launched in June 2022 to expand its newborn screening to include spinal muscular atrophy, serve to enhance the screening landscape, encouraging wider adoption and implementation of screening protocols. As the understanding of congenital disorders deepens and societal emphasis on early detection intensifies, the newborn screening market is expected to see considerable expansion through 2031. The convergence of these elements establishes a favorable climate for innovation and investment in newborn screening, positioning it as a critical area of focus for stakeholders in the healthcare sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Newborn Screening market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Newborn Screening Market Segmental Analysis

Global Newborn Screening Market is segmented by Product, Test, technology, end user and region. Based on Product, the market is segmented into Consumables, Instruments, Hearing screening instruments, Pulse oximeters. Based on Test, the market is segmented into Dry blood spot tests, Hearing screening tests, CCHD screening tests. Based on technology, the market is segmented into Immune assays & enzymatic assays, Tandem mass spectrometry, Molecular assays, Hearing screening technologies, Pulse oximetry, Other Technologies. Based on end user, the market is segmented into Clinical Laboratories, Hospitals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Newborn Screening Market

The rising prevalence of congenital abnormalities is a key market driver for the Global Newborn Screening market, fueling demand for early diagnostic solutions. Conditions such as genetic disorders, hearing impairments, and metabolic disorders emphasize the need for prompt identification and intervention, which can significantly enhance treatment outcomes and the quality of life for affected neonates. As medical technology advances and understanding of the benefits of early diagnosis deepens, the importance of comprehensive screening programs becomes increasingly evident. Additionally, heightened awareness of congenital disorders and focused initiatives to safeguard newborn health are encouraging the adoption of thorough screening techniques, thus bolstering market growth.

Restraints in the Global Newborn Screening Market

The high cost of newborn screening tests presents a significant market restraint, particularly impacting low- and middle-income countries. These financial barriers restrict access to essential screening, preventing families from benefiting from potentially lifesaving treatments. As a result, the delay in detection and intervention can severely compromise the health outcomes of affected neonates. Furthermore, the existing disparity in access to these critical tests highlights the urgent need for more affordable screening options and support networks that promote equitable early diagnostic services. Addressing this monetary limitation is crucial for advancing global infant health and ensuring all newborns receive adequate care.

Market Trends of the Global Newborn Screening Market

The Global Newborn Screening market is witnessing a significant trend towards advanced genetic testing integration, characterized by the adoption of Whole Genome Sequencing (WGS) and Next-Generation Sequencing (NGS). These innovative technologies facilitate the precise identification of a broader range of genetic disorders, including complex and rare conditions often overlooked by traditional methods. As the costs associated with genetic testing continue to decline, the availability of comprehensive screening panels is expanding, enabling earlier and more accurate detection of genetic abnormalities. This evolution not only enhances the efficacy of newborn screening programs but also improves clinical outcomes, driving demand and growth within the market.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Patent Analysis
Value Chain Analysis
Case Study Analysis
Market Attractiveness Index

Global Newborn Screening Market Size by Product & CAGR (2024-2031)

Market Overview
Consumables
Instruments
Hearing screening instruments
Pulse oximeters

Global Newborn Screening Market Size by Test & CAGR (2024-2031)

Market Overview
Dry blood spot tests
Hearing screening tests
CCHD screening tests

Global Newborn Screening Market Size by Technology & CAGR (2024-2031)

Market Overview
Immune assays & enzymatic assays
Tandem mass spectrometry
Molecular assays
Hearing screening technologies
Pulse oximetry
Other Technologies

Global Newborn Screening Market Size by End User & CAGR (2024-2031)

Market Overview
Clinical Laboratories
Hospitals

Global Newborn Screening Market Size & CAGR (2024-2031)

North America, (Product, Test, Technology, End User)
- US
- Canada
Europe, (Product, Test, Technology, End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Product, Test, Technology, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Product, Test, Technology, End User)
- Brazil
- Rest of Latin America
Middle East & Africa, (Product, Test, Technology, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Masimo Corp.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Covidien Plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AB Sciex LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Natus Medical Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trivitron Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rady Children's Institute for Genomic Medicine
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Lifesciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Waters Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZIVAK TECHNOLOGIES
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CAMAG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OTODYNAMICS
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZENTECH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
VIVOSONIC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

新生児スクリーニングの市場規模・シェア・成長分析 (製品別、技術別、検査の種類別、地域別)：産業予測 (2024～2031年)

Newborn Screening Market Size, Share, Growth Analysis, By Product (Consumables, Instruments), By Technology (Tandem Mass Spectrometry, Pulse Oximetry), By Test Type (Dry Blood Spot Test, CCHD), By Region - Industry Forecast 2024-2031

目次

イントロダクション

分析手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

世界の新生児スクリーニングの市場規模 (製品別)・CAGR (2024～2031年)

世界の新生児スクリーニングの市場規模 (検査別)・CAGR (2024～2031年)

世界の新生児スクリーニングの市場規模 (技術別)・CAGR (2024～2031年)

世界の新生児スクリーニングの市場規模 (エンドユーザー別)・CAGR (2024～2031年)

世界の新生児スクリーニングの市場規模・CAGR (2024～2031年)